RobertPFrantzMD

Cardiology • Rochester, MN

Adult Congenital Heart Disease, Heart Failure & Transplantation

Cardiology at Mayo Clinic Rochester MN

Join to view full profile

Dr. Frantz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Frantz's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

University of RochesterFellowship, Cardiovascular Disease, 1987 - 1990
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1987
Mayo Clinic College of MedicineClass of 1984

Certifications & Licensure

NY State Medical License 1987 - Present
IA State Medical License 1993 - 2026
ND State Medical License 2009 - 2026
MN State Medical License 1985 - 2025
WI State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Start of enrollment: 2009 Dec 01
Completed
Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA) Start of enrollment: 2008 May 01
Completed
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Pulmonary Hypertension Association Registry Start of enrollment: 2015 Oct 01
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1197 citations
Definitions and diagnosis of pulmonary hypertension.
Marius M. Hoeper, Harm Jan Bogaard, Robin Condliffe, Robert P. Frantz, Dinesh Khanna
Journal of the American College of Cardiology. 2013-12-24
379 citations
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.
Raymond L. Benza, Mardi Gomberg-Maitland, Dave P. Miller, Adaani E. Frost, Robert P. Frantz
Chest. 2012-02-01
5 citations
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm.
Robert P. Frantz
The European Respiratory Journal. 2015-08-01

Lectures

Mayo Clinic Interventional Cardiology Board Review
Mayo School of Continuous Professional Development, Rochester, Minnesota - 10/12/2012

Authored Content

Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Join now to see all

Press Mentions

Episode 475 - Robert Frantz, MDJuly 1st, 2024
Novel PAH Drug Shows Promise in Mid-Stage TrialMay 23rd, 2023
I’m Aware That I’m Rare: Robert P. Frantz, MDNovember 16th, 2018
Join now to see all

Grant Support

Sildenafil On Alveolar-Capillary Recruitment, Pulmonary Arterial Pressures And ENational Center For Research Resources2005
Pulmonary Limitations In Chronic Heart FAILURE: Influence Of ACE Genotype On ExeNational Center For Research Resources2005

Professional Memberships

American College of Cardiology - ACC
Member